BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Distillery Therapeutics

Small molecule to control β cell ER stress in diabetes

By biocentury staff
April 1, 2022 5:02 AM UTC

DISEASE CATEGORY: Endocrine/metabolic

INDICATION: Diabetes...

BCIQ Company Profiles

Tokushima University

BCIQ Target Profiles

Activating transcription factor 4 (ATF4)

Activating transcription factor 6 (ATF6)

Heat shock 70 kDa protein 5 (glucose-regulated protein, 78kDa) (GRP78) (HspA5)

X-box binding protein 1 (XBP1)

BCIQ Company Profiles

Tokushima University

BCIQ Target Profiles

Activating transcription factor 4 (ATF4)

Activating transcription factor 6 (ATF6)

Heat shock 70 kDa protein 5 (glucose-regulated protein, 78kDa) (GRP78) (HspA5)

X-box binding protein 1 (XBP1)

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2025 BioCentury Inc. All Rights Reserved.
Copyright © 2025 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS